Brief: Tempest Announces Closing Of Strategic Acquisition Of Dual-Targeting Car-T Assets
04/02/2026 21:47
Feb 4 (Reuters) - Tempest Therapeutics Inc TPST.O: TEMPEST ANNOUNCES CLOSING OF STRATEGIC ACQUISITION OF DUAL-TARGETING CAR-T ASSETS Source text: ID:nGNXLDmjv Further company coverage: TPST.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tempest Therapeutics
See all newsBrief: Tempest Therapeutics - Justin Trojanowski To Resign As Principal Financial Officer And Principal Accounting Officer Effective Sept 1 - SEC Filing
Tempest Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tempest Therapeutics - Enters $50 Million Common Stock Purchase Agreement With Lincoln Park
Tempest Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Tempest Announces Development Collaboration With Senlang Biotechnology For TPST-4003, A CD7-Targeted Next-Generation In Vivo CAR-T